Vyvanse and Skin warm - a phase IV clinical study of FDA data

Summary:

Skin warm is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Inflectra, and have Crohn's disease.

The phase IV clinical study analyzes which people have Skin warm when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.

What is Skin warm?

Skin warm is found to be associated with 618 drugs and 764 conditions by eHealthMe. Check the latest studies of Skin warm.

On Aug, 13, 2026

28,083 people reported to have side effects when taking Vyvanse.
Among them, 12 people (0.04%) have Skin warm.

Among these 12 people:

How long have people been on Vyvanse when they have Skin warm? *

What is the gender of people who have Skin warm when taking Vyvanse? *

female: 50 %
male: 50 %

What is the age of people who have Skin warm when taking Vyvanse? *

What are other drugs people take besides Vyvanse? *

What are other side effects people have besides Skin warm? *

Rashes (redness): 7 people, 58.33%
Joint Pain: 4 people, 33.33%
Rash Pruritic (redness with itching): 4 people, 33.33%
Hypersensitivity: 4 people, 33.33%
Influenza Like Illness: 3 people, 25.00%
Dry Skin: 3 people, 25.00%
Pain: 3 people, 25.00%
Furuncle (infection of the hair follicle): 3 people, 25.00%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 25.00%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 25.00%
Pain: 2 people, 16.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 16.67%
Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 8.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Kawasaki's Disease (an autoimmune disease in which the medium-sized blood vessels throughout the body become inflamed): 1 person, 8.33%
Drug Dependence: 1 person, 8.33%
Alcoholism (problems with alcohol): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and have Skin warm?

- Check whether Skin warm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vyvanse:

Vyvanse (35,870 reports)

Skin warm treatments and more:

Skin warm (6,515 reports)

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin warm:

Skin warm (618 drugs)

Browse all the conditions that are associated with Skin warm:

Skin warm (764 conditions)

Related publications that referenced our studies

Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.